Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PECS Block for Persistent Pain After Breast Cancer Surgery
NCT02349581Phase 2Unknown
- Sponsor
- Rigshospitalet
- Start
- Nov 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine in chronic postsurgical pain (CPSP), sponsored by Rigshospitalet. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT02349581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02349581.